Home
>
National Drug Code (NDC)
>
Acarbose
Acarbose - 16252-525-01 - (Acarbose)
Drug Information of Acarbose
| Product NDC: | 16252-525 |
| Proprietary Name: | Acarbose |
| Non Proprietary Name: | Acarbose |
| Active Ingredient(s): | 100 mg/1 & nbsp; Acarbose |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Acarbose
| Product NDC: | 16252-525 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077532 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080507 |
Package Information of Acarbose
| Package NDC: | 16252-525-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (16252-525-01) |
NDC Information of Acarbose
| NDC Code | 16252-525-01 |
| Proprietary Name | Acarbose |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (16252-525-01) |
| Product NDC | 16252-525 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acarbose |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080507 |
| Marketing Category Name | ANDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | ACARBOSE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
